These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 35046705)
1. Identification of PDCD1 and PDCD1LG2 as Prognostic Biomarkers and Associated with Immune Infiltration in Hepatocellular Carcinoma. Li W; Mei M; Liu T; Zhang S; Wang Z; Suo Y; Wang S; Liu Y; Zhang N; Lu W Int J Gen Med; 2022; 15():437-449. PubMed ID: 35046705 [TBL] [Abstract][Full Text] [Related]
2. Identification of the Prognosis Value and Potential Mechanism of Immune Checkpoints in Renal Clear Cell Carcinoma Microenvironment. Liao G; Wang P; Wang Y Front Oncol; 2021; 11():720125. PubMed ID: 34336706 [TBL] [Abstract][Full Text] [Related]
3. Exploring Prognosis, Tumor Microenvironment and Tumor Immune Infiltration in Hepatocellular Carcinoma Based on ATF/CREB Transcription Factor Family Gene-Related Model. Shen H; Gu X; Li H; Tang M; Li X; Zhang Y; Su F; Wang Z J Hepatocell Carcinoma; 2023; 10():327-345. PubMed ID: 36874250 [TBL] [Abstract][Full Text] [Related]
4. Prognostic and immune correlation evaluation of a novel cuproptosis-related genes signature in hepatocellular carcinoma. Zhou Z; Zhou Y; Liu D; Yang Q; Tang M; Liu W Front Pharmacol; 2022; 13():1074123. PubMed ID: 36588699 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of POLA2 in hepatocellular carcinoma is involved in immune infiltration and predicts a poor prognosis. Liu L; Wang Q; Wu L; Zhang L; Huang Y; Yang H; Guo L; Fang Z; Wang X Cancer Cell Int; 2023 Jul; 23(1):138. PubMed ID: 37452331 [TBL] [Abstract][Full Text] [Related]
6. Cell division cycle-associated 8 is a prognostic biomarker related to immune invasion in hepatocellular carcinoma. Wu H; Liu S; Wu D; Zhou H; Sui G; Wu G Cancer Med; 2023 Apr; 12(8):10138-10155. PubMed ID: 36855818 [TBL] [Abstract][Full Text] [Related]
7. A Novel Nine-Gene Signature Associated With Immune Infiltration for Predicting Prognosis in Hepatocellular Carcinoma. Liu R; Jiang Z; Kong W; Zheng S; Dai T; Wang G Front Genet; 2021; 12():730732. PubMed ID: 34917126 [No Abstract] [Full Text] [Related]
8. MJDs family members: Potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma. Zhou L; Chen G; Liu T; Liu X; Yang C; Jiang J Front Genet; 2022; 13():965805. PubMed ID: 36159990 [TBL] [Abstract][Full Text] [Related]
9. Differential expression of individual transcript variants of PD-1 and PD-L2 genes on Th-1/Th-2 status is guaranteed for prognosis prediction in PCNSL. Takashima Y; Kawaguchi A; Sato R; Yoshida K; Hayano A; Homma J; Fukai J; Iwadate Y; Kajiwara K; Ishizawa S; Hondoh H; Nakano M; Ogawa S; Tashiro K; Yamanaka R Sci Rep; 2019 Jul; 9(1):10004. PubMed ID: 31292525 [TBL] [Abstract][Full Text] [Related]
10. Identification of the Tumor Immune Microenvironment and Therapeutic Biomarkers by a Novel Molecular Subtype Based on Aging-Related Genes in Hepatocellular Carcinoma. Cai D; Zhao Z; Hu J; Dai X; Zhong G; Gong J; Qi F Front Surg; 2022; 9():836080. PubMed ID: 35392063 [TBL] [Abstract][Full Text] [Related]
11. Identification METTL18 as a Potential Prognosis Biomarker and Associated With Immune Infiltrates in Hepatocellular Carcinoma. Li TH; Qin C; Zhao BB; Cao HT; Yang XY; Wang YY; Li ZR; Zhou XT; Wang WB Front Oncol; 2021; 11():665192. PubMed ID: 34123827 [TBL] [Abstract][Full Text] [Related]
12. CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma. Lin T; Zhang E; Mai PP; Zhang YZ; Chen X; Peng LS Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34085699 [TBL] [Abstract][Full Text] [Related]
13. An Inflammatory Response-Related Gene Signature Can Impact the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma. Lin Z; Xu Q; Miao D; Yu F Front Oncol; 2021; 11():644416. PubMed ID: 33828988 [TBL] [Abstract][Full Text] [Related]
14. Significant correlation between HSPA4 and prognosis and immune regulation in hepatocellular carcinoma. Shang BB; Chen J; Wang ZG; Liu H PeerJ; 2021; 9():e12315. PubMed ID: 34754620 [TBL] [Abstract][Full Text] [Related]
15. CDT1 Is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma. Cai C; Zhang Y; Hu X; Hu W; Yang S; Qiu H; Chu T Front Oncol; 2021; 11():721644. PubMed ID: 34631549 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value and immunological role of PDCD1 gene in pan-cancer. Miao Y; Wang J; Li Q; Quan W; Wang Y; Li C; Wu J; Mi D Int Immunopharmacol; 2020 Dec; 89(Pt B):107080. PubMed ID: 33069926 [TBL] [Abstract][Full Text] [Related]
17. Integrative study reveals the prognostic and immunotherapeutic value of CD274 and PDCD1LG2 in pan-cancer. Zhou X; Wang Y; Zheng J; Wang S; Liu C; Yao X; Ren Y; Wang X Front Genet; 2022; 13():990301. PubMed ID: 36276934 [No Abstract] [Full Text] [Related]
18. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis. Zhang QB; Jia QA; Wang H; Hu CX; Sun D; Jiang RD; Zhang ZL BMC Cancer; 2016 Nov; 16(1):880. PubMed ID: 27836008 [TBL] [Abstract][Full Text] [Related]
19. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma. Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238 [TBL] [Abstract][Full Text] [Related]
20. The identification of a PTEN-associated gene signature for the prediction of prognosis and planning of therapeutic strategy in endometrial cancer. Zhang Y; Li L; Ke XP; Liu P Transl Cancer Res; 2023 Dec; 12(12):3409-3424. PubMed ID: 38192993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]